Related Experiment Video
Updated: Aug 8, 2026

10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
The scientific challenge of Langerhans cell histiocytosis
1Imperial Cancer Research Fund Tumour Immunology Unit, University College London Medical School, U.K.
The British Journal of Cancer. Supplement
|September 1, 1994
Abstract:
Langerhans cell histiocytosis is difficult to study because of its rarity. Although recent studies indicate that it may be a clonal proliferation this does not prove that it is a malignant tumour. New methods for culturing dendritic cells and their precursors provide the opportunity to resolve issues relating to clonality, underlying genetic lesions and functional abnormalities in LCH or other lesional cells. The expression of the CD1a antigen on LCH cells provides a target for therapy.

